TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

TGA presentation given at the RACI Pharmaceutical Science Group Seminar, 10 August 2015

TGOs versus Pharmacopoeias. Do I have a choice?

11 August 2015

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

Presentation

  • Presented by: Jenny Burnett, Director, Scientific Operations Management, Scientific Evaluation Branch, Therapeutic Goods Administration
  • Presented at: RACI Pharmaceutical Science Group Seminar, 10 August 2015
  • Presentation summary: This presentation is an overview of TGOs versus pharmacopoeias and how these are incorporated into the Australian legislation.

Transcript

TGOs versus Pharmacopoeias - Do I have a choice?

Jenny Burnett
Director
Scientific Operations Management
Scientific Evaluation Branch
Therapeutic Goods Administration

RACI Pharmaceutical Science Group Seminar, 10 August 2015

Slide 1 - Outline

  • Why we have TGOs and pharmacopoeias
  • How these are incorporated in the Australian legislation
  • When these standards are applied
  • Where you can find information on these requirements

Slide 2 - Quality is important

  • Australian legislation for a system of controls relating to safety, quality and efficacy
    • Therapeutic Goods Act 1989
  • Therapeutic Goods Administration administers the Act (and supporting legislation)

Slide 3 - TGA's role as regulator

  • Ensure quality, safety, efficacy and timely availability
  • 'Quality' is reviewed:
    • pre-market assessment
    • Good Manufacturing Practice requirements
    • post-market review
    • testing
  • Legislative responsibilities for both TGA and sponsors

Slide 4 - Legislative requirements

  • Section 14 and 14A of the Act
    • penalties for importing, supplying, exporting goods that do not comply with standards
  • Section 25 of the Act
    • '... must evaluate having regard to ... whether the goods conform to any standard applicable to the goods'
  • Section 26 of the Act
    • '... not to refuse to list ... except where ... the goods do not conform to a standard applicable to the goods'
  • Section 26A of the Act
    • '... applicant must certify that ... the medicine conforms to every standard applicable to the medicine'

Slide 5 - How do we measure quality?

  • is there more to life than the BP??

Slide 6 - Australian Legislation - Standards

Section 3 of the Act

A standard means any of the following

  • a standard specified under section 10 of the Act
  • statements in a monograph in the British Pharmacopoeia
  • statements in a monograph in the European Pharmacopoeia
  • statements in a monograph in the United States Pharmacopeia - National Formulary

But which one???

Slide 7 - Default standards

  • BP/EP/USP
  • Automatic adoption of new versions
  • Responsibility for compliance with revised monographs - stay up to date!
  • Multiple default standards may exist for the same goods

Slide 8 - Ministerial Determinations

Section 3C of the Act provides the power to exempt

  • monographs in the BP/EP/USP
  • statements in the BP/EP/USP

from being standards under section 3

For example, Therapeutic Goods (exempting monographs of pharmacopoeias) Determination No. 1 of 2011

Certain vaccines and 'immune globulins' (USP)

Slide 9 - Ministerial standards

Section 10 of the Act

  • Power for the Minister to make an order - legislative instrument
  • An order can be
    • related to quality/quantity/manufacture/labelling and packaging/testing requirements
    • a monograph in either the BP/EP/USP
    • a modified monograph
    • a standard published by Standards Australia
    • 'such other matters as the minister thinks fit'

Slide 10 - So, can I choose?

Section 13 of the Act: an applicable Ministerial standard + a default standard then the default standard is disregarded where they are inconsistent

Slide 11 - Creation of TGOs

  • Can specify a new Order even if there is an applicable default standard
  • Must consult the Therapeutic Goods Committee
  • Registered on the Federal Register of Legislative Instruments
  • Available on the Comlaw website

Slide 11 - What is out there?

Print version

How to access a pdf document